John Lothian News interviewed Michael Riddle, CEO of Eris Innovations, and Agha Mirza, managing director and global head of rates and OTC products for the CME Group about the success of the Eris SOFR products trading on the CME.
JLN asked about the origin story of the Eris products and when they began to trade on the CME.
We asked about the recent events that have driven the growth of the products. We asked about the impact of the regional banking crisis on the products.
Riddle and Mirza also discussed who the users of the products are and what plans Eris Innovations has to extend the product mix in the next three to five years.
A CME Group member since the early 1990s, Revolution Global Chief Executive Officer Mark de Souza is taking his experience in risk management and...
JLN spoke to Luc Fortin, president of TMX’s Montreal Exchange, about its newest short term interest rate product, CORRA futures, which launched in June....
Veteran broker decries HFT “parasites,” maker‑taker rebates and looming Rule 611 overhaul, warns SEC tokenization push could hurt retail while leaving core market flaws...
